Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for Chronic Nausea in Advanced Cancer
NCT00006348Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Oct 2000
- Primary completion
- Sep 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ondansetron in nausea ((none)), Vomiting, sponsored by Cancer and Leukemia Group B. Started Oct 2000; status: completed.
02
Drugs
ondansetron
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT00006348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006348.